×
Back to Agenda
Session 5: Biologics - Innovation and Challenges from CMC Perspective
Session Chair(s)
Ho Jung Oh
Director NIFDS
Ministry of Food and Drug Safety, Korea, Republic of
Speaker(s)
CMC-Related Technical And Regulatory Aspects For Development Of Biotherapeutic Products
JunTae Park
Helixmith, Korea, Republic of
Senior vice president of licensing and regulatory affairs
Antibody Drug Manufacturing And Quality Control (Tentative)
Sangyoon Lee
Celltrion, United States
Have an account?